MX2010000468A - Formulaciones estables de derivado de tiadiazol. - Google Patents

Formulaciones estables de derivado de tiadiazol.

Info

Publication number
MX2010000468A
MX2010000468A MX2010000468A MX2010000468A MX2010000468A MX 2010000468 A MX2010000468 A MX 2010000468A MX 2010000468 A MX2010000468 A MX 2010000468A MX 2010000468 A MX2010000468 A MX 2010000468A MX 2010000468 A MX2010000468 A MX 2010000468A
Authority
MX
Mexico
Prior art keywords
derivatiive
thiadiazole
stable formulations
ethanesulfo
nylamino
Prior art date
Application number
MX2010000468A
Other languages
English (en)
Inventor
Hiroko Kusano
Dinesh Shyamdeo Mishra
Yoshikazu Tashiro
Yosuke Watanabe
Hong Zhuang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39735000&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010000468(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2010000468A publication Critical patent/MX2010000468A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invenci?n provee par?metros de formulaci?n y condiciones de fabricaci?n para composiciones farmac?uticas estables que comprenden N-{4-(2,2-dimetilpropionil)-(5R)-5-[(2-eti lamino-etansulfonilamino)-metil]-5-fenil-4,5-dihidro-[l,3,4]tiadi azol-2-il}-2,2-dimetil-propionamida que minimiza la conversi?n quiral indeseable a la forma enantiom?rica S menos activa.
MX2010000468A 2007-07-12 2008-07-07 Formulaciones estables de derivado de tiadiazol. MX2010000468A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94926807P 2007-07-12 2007-07-12
PCT/US2008/069301 WO2009009470A1 (en) 2007-07-12 2008-07-07 Stable formulations of thiadiazole derivatiive

Publications (1)

Publication Number Publication Date
MX2010000468A true MX2010000468A (es) 2010-04-09

Family

ID=39735000

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010000468A MX2010000468A (es) 2007-07-12 2008-07-07 Formulaciones estables de derivado de tiadiazol.

Country Status (28)

Country Link
US (1) US8222284B2 (es)
EP (1) EP2178508B1 (es)
JP (1) JP4875205B2 (es)
KR (1) KR101188036B1 (es)
CN (1) CN101730525A (es)
AR (1) AR067472A1 (es)
AU (1) AU2008275258A1 (es)
BR (1) BRPI0814039A2 (es)
CA (1) CA2694277C (es)
CL (1) CL2008001996A1 (es)
CO (1) CO6270304A2 (es)
CR (1) CR11210A (es)
DO (1) DOP2010000004A (es)
EA (1) EA016861B1 (es)
EC (1) ECSP109864A (es)
ES (1) ES2401477T3 (es)
GT (1) GT201000003A (es)
HK (1) HK1141238A1 (es)
IL (1) IL202382A0 (es)
MA (1) MA31880B1 (es)
MX (1) MX2010000468A (es)
NZ (1) NZ581791A (es)
PE (1) PE20090438A1 (es)
SV (1) SV2010003449A (es)
TN (1) TN2010000015A1 (es)
TW (1) TW200918050A (es)
UA (1) UA97672C2 (es)
WO (1) WO2009009470A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102459909B (zh) 2009-06-26 2014-12-10 三菱电机株式会社 制冷剂压缩机

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469801C (en) 2001-12-11 2011-06-21 Kyowa Hakko Kogyo Co., Ltd. Thiadiazoline derivative
JP4676881B2 (ja) * 2003-04-18 2011-04-27 協和発酵キリン株式会社 Ｍ期キネシン阻害剤
JP2008137893A (ja) * 2005-03-22 2008-06-19 Kyowa Hakko Kogyo Co Ltd 関節炎治療剤
JP2006265107A (ja) * 2005-03-22 2006-10-05 Kyowa Hakko Kogyo Co Ltd 緑内障治療剤
KR20070114822A (ko) * 2005-03-22 2007-12-04 교와 핫꼬 고교 가부시끼가이샤 조혈기 종양 치료제
WO2006101102A1 (ja) * 2005-03-22 2006-09-28 Kyowa Hakko Kogyo Co., Ltd. 固形腫瘍治療剤
JP2008150291A (ja) * 2005-03-22 2008-07-03 Kyowa Hakko Kogyo Co Ltd 乾癬治療剤
WO2006137490A1 (ja) * 2005-06-24 2006-12-28 Kyowa Hakko Kogyo Co., Ltd. 再狭窄治療剤

Also Published As

Publication number Publication date
TN2010000015A1 (en) 2011-09-26
BRPI0814039A2 (pt) 2017-10-03
IL202382A0 (en) 2010-06-30
EP2178508A1 (en) 2010-04-28
KR20100029827A (ko) 2010-03-17
JP2010533190A (ja) 2010-10-21
ES2401477T3 (es) 2013-04-19
CA2694277A1 (en) 2009-01-15
AU2008275258A1 (en) 2009-01-15
MA31880B1 (fr) 2010-12-01
CO6270304A2 (es) 2011-04-20
US8222284B2 (en) 2012-07-17
NZ581791A (en) 2012-03-30
ECSP109864A (es) 2010-03-31
WO2009009470A1 (en) 2009-01-15
JP4875205B2 (ja) 2012-02-15
UA97672C2 (ru) 2012-03-12
CA2694277C (en) 2013-04-09
GT201000003A (es) 2012-03-13
AR067472A1 (es) 2009-10-14
EA016861B1 (ru) 2012-08-30
SV2010003449A (es) 2010-08-10
EA201070136A1 (ru) 2010-06-30
US20110009458A1 (en) 2011-01-13
CR11210A (es) 2010-06-23
CN101730525A (zh) 2010-06-09
HK1141238A1 (en) 2010-11-05
CL2008001996A1 (es) 2009-05-22
EP2178508B1 (en) 2013-02-06
DOP2010000004A (es) 2010-03-15
PE20090438A1 (es) 2009-04-18
TW200918050A (en) 2009-05-01
KR101188036B1 (ko) 2012-10-05

Similar Documents

Publication Publication Date Title
WO2009082152A3 (en) Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
WO2010041141A3 (en) Oil-based foamable carriers and formulations
WO2005080345A3 (en) Imidazoline derivatives having cb1-antagonistic activity
WO2011148328A3 (en) Cosmetic process for making-up and/or caring for the skin and/or the lips
PL1940249T3 (pl) Nowe formulacje rozpuszczalnych w tłuszczach składników aktywnych o wysokiej biodostępności
WO2010001169A3 (en) Chemical compounds 251
WO2012007869A3 (en) N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
WO2010103130A3 (en) Thiazolopyrimidine modulators as immunosuppressive agents
WO2008054698A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
HK1142536A1 (en) Gel useful for the delivery of cosmetic active ingredients
WO2005075471A3 (en) Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
WO2007058862A3 (en) Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
WO2009105969A8 (zh) 埃坡霉素类似物、其药物组合物、用途及其制备方法
WO2012054356A3 (en) Cross connectors
WO2010054757A8 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
WO2009060952A1 (ja) 新規製剤
WO2005058890A3 (en) Hydronopol derivatives as agonists on human orl1 receptors
WO2006121717A3 (en) Skin care compositions containing idebenone
MA30292B1 (fr) Amines primaires comme inhibiteurs de la renine
WO2008014361A3 (en) Cyclic derivatives as modulators of chemokine receptor activity
WO2006021401A3 (en) Bicylononene derivatives
EP2371379A3 (en) New formulation for increasing bioavailability of neurturin
WO2008027533A3 (en) Personal care compositions comprising pear seed extract
MX2010000468A (es) Formulaciones estables de derivado de tiadiazol.

Legal Events

Date Code Title Description
FG Grant or registration